Senior Principal Scientist, Long-acting Sterile Product Development

Merck Merck · Pharma · NJ

Senior Principal Scientist role focused on late-stage development of long-acting injectable (LAI) drug products, including depot formulations and extended-release systems. Responsibilities include leading formulation and delivery strategy, providing technical leadership on cross-functional teams, designing studies for release kinetics and stability, supporting process scale-up and validation, and partnering with regulatory and quality teams. Requires deep expertise in parenteral drug product development and LAI formulations.

What you'd actually do

  1. Serve as a senior principal‑level LAI formulation scientist, providing scientific leadership for the design, development, and lifecycle management of long‑acting injectable drug products with line of sight to commercialization, including depot, sustained‑release, and controlled‑delivery parenteral dosage forms.
  2. Lead LAI formulation and delivery strategy development, including selection and optimization of release mechanisms (e.g., polymer‑based depots, suspensions, microspheres, in situ forming systems), excipient systems, and delivery approaches to meet target product profiles
  3. Provide strategic technical leadership on cross‑functional program teams, ensuring alignment of formulation, drug substance properties, delivery system performance, container/closure systems, manufacturability, and clinical use considerations throughout development and with strong line of sight to commercialization.
  4. Design and interpret studies to understand and control release kinetics, stability, and performance, including: - Drug–excipient and drug–polymer interactions - In vitro and in vivo performance relationships - Physical stability, aggregation, and particle size control - Syringeability, injectability, and device compatibility
  5. Support early‑ and late‑stage development programs, including: - Selection of scalable manufacturing processes for LAIs - Definition of formulation and process design space - Support for clinical and commercial process scale‑up and validation - Technology transfer to GMP manufacturing facilities

Skills

Required

  • Deep expertise in parenteral drug product development, with demonstrated experience in long‑acting injectable or sustained‑release formulations
  • Strong scientific understanding of controlled‑release mechanisms and LAI delivery systems
  • Strong scientific understanding of drug–polymer and drug–excipient interactions
  • Strong scientific understanding of formulation stability and performance characterization
  • Experience applying Quality by Design (QbD) principles and DOE approaches to formulation and process development
  • Experience supporting process scale‑up, validation, and technology transfer for sterile injectable products
  • Working knowledge of CMC regulatory expectations for parenteral and extended‑release products, including development‑stage and commercial submissions
  • Demonstrated ability to lead cross‑functional teams, influence strategy, and communicate complex scientific concepts clearly
  • Proven mentoring and scientific leadership skills at the senior/principal level
  • Biopharmaceutics
  • Chemical Engineering
  • Commercialization
  • GMP Compliance
  • Innovative Thinking
  • Interpersonal Relationships
  • Manufacturing Processes
  • Materials Science
  • Materials Technology
  • Mentorship
  • Parenterals
  • Process Characterization
  • Product Development
  • Project Leadership
  • Scientific Leadership
  • Sterile Injectables
  • Technical Leadership

Nice to have

  • Experience with LAI‑specific platforms, such as polymer depots, microspheres, nanosuspensions, or in situ forming systems
  • Experience with device–drug product integration, including prefilled syringes or delivery systems relevant to LAIs
  • Experience with late-stage product development, including Ph3 and commercial filings
  • Understanding of clinical and patient‑centric considerations influencing LAI design (e.g., dosing interval, injection volume, administration route)
  • Experience supporting global regulatory filings and health authority interactions
  • Track record of contributing to publications, patents, or external scientific collaborations in drug delivery or formulation science
  • Device–drug product integration
  • Late-stage product development
  • Clinical and patient-centric considerations
  • Global regulatory filings
  • Health authority interactions
  • Publications
  • Patents
  • External scientific collaborations